Skip to main content

Clinical Management of Tourette Syndrome with Clonidine

  • Chapter
Movement Disorders
  • 66 Accesses

Abstract

The demonstration of clonidine’s effectiveness in Tourette syndrome (TS) (Ashanuddin et al.,1980; Cohen et al., 1979, 1980; Dorsey, 1981) substantially expanded the pharmacological options in the management of this condition. For the preceding decade, the only clearly effective medication was haloperidol, and before that, TS sufferers received a host of treatments ranging from psychotherapy to behavior modification to electroconvulsive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abuzzahab, F. S., and Anderson, F. O., 1973, Giles de la Tourette syndrome, International Registry, Minn. Med. 56: 492–496.

    PubMed  Google Scholar 

  • Ashanuddin, K., Hall, K., Kowall, M., and Prosen, H., 1980, Tourette’s syndrome-treatment with clonidine, A centrally acting alpha-adrenergic agonist, Drug. Intell., Clin. Pharmacol. 14 (32): 288–289.

    Google Scholar 

  • Brun, R. D., 1982, Clonidine treatment of Tourette’s syndrome, Adv. Neurol. 35: 403–405.

    Google Scholar 

  • Cohen, D. J., Young, J. G., Nathanson, J. A., and Shaywitz, B. A., 1979, Clonidine in Tourette’s syndrome, Lancet H 8142: 551–553.

    Google Scholar 

  • Cohen, D. J., Detlor, J., Lowe, T., 1980, Clonidine ameliorates Gilles de la Tourette syndrome, Arch. Gen. Psychiatry 37 (12): 1350–1357.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, D. J., et al.,1982, Stimulant medications in Tourette’s syndrome, DAMA 248:1062–1063.

    Google Scholar 

  • Dorsey, R., 1981, Clonidine and Gilles de la Tourette syndrome, Arch. Gen. Psychiatry 38 (10): 1185.

    Article  PubMed  CAS  Google Scholar 

  • Leckman, J. F., Cohen, D. J., Detlor, J., Young, J. G., Harchurik, D., and Shawitz, B. A., 1982, Clonidine in the treatment of Tourette syndrome: A review of data, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35, pp. 391–402, Raven Press, New York.

    Google Scholar 

  • Nee, L. E., Polinsky, R. J., and Ebert, M. H., 1980, Gilles de la Tourette syndrome: Clinical and family study of fifty cases, Ann. Neurol. 7 (1): 41–49.

    Article  PubMed  CAS  Google Scholar 

  • Shapiro, A. K., and Shapiro, E., 1984, Controlled study of Pimizide vs. placebo in Tourette syndrome, J. Am. Acad. Child Psychiatry 23 (2): 161–173.

    Article  PubMed  CAS  Google Scholar 

  • Shapiro, A. K., and Shapiro, E., 1982, Advances in Neurology, Vol. 35, pp. 283–286, Raven Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Publishing Corporation

About this chapter

Cite this chapter

Dorsey, R. (1986). Clinical Management of Tourette Syndrome with Clonidine. In: Shah, N.S., Donald, A.G. (eds) Movement Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5038-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5038-5_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5040-8

  • Online ISBN: 978-1-4684-5038-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics